Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cowen Group Inc (COWN)

Cowen Group Inc (COWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cowen Group Inc 599 LEXINGTON AVENUE NEW YORK NY 10022 USA

www.cowen.com P: 646-562-1010

Description:

COWEN GROUP, INC., through its operating subsidiaries, provides investment banking, equity research, sales and trading, asset management and alternative asset management services to companies and institutional investor clients in the healthcare, technology, telecommunications, aerospace and defense, consumer and alternative energy sectors. Cowen's asset management business includes teams based in the U.S. and the U.K. Cowen's U.S. team focuses on a growth-oriented investment style centered on small and mid-sized companies based primarily in North America. Cowen's U.K. team provides traditional asset management products, focusing on a global equity strategy. Cowen's alternative asset management business consists of Cowen Healthcare Royalty Partners, which invests principally in commercial-stage biopharmaceutical products and companies, and Cowen Capital Partners, which manages a portfolio of middle market private equity investments for third party investors.

Key Statistics

Overview:

Market Capitalization, $K 1,092,266
Enterprise Value, $K -1,705,694
Shares Outstanding, K 28,014
Annual Sales, $ 1,538 M
Annual Net Income, $ 76,460 K
Last Quarter Sales, $ 413,930 K
Last Quarter Net Income, $ 12,930 K
60-Month Beta 1.41
% of Insider Shareholders 5.40%
% of Institutional Shareholders 93.10%
Float, K 26,501
% Float 94.60%
Short Volume Ratio 0.19

Growth:

1-Year Return 31.50%
3-Year Return 178.90%
5-Year Return 170.76%
5-Year Revenue Growth 133.42%
5-Year Earnings Growth 372.22%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.29 on 02/17/23
Next Earnings Date N/A
Earnings Per Share ttm 2.52
EPS Growth vs. Prev Qtr -61.84%
EPS Growth vs. Prev Year -89.53%
Annual Dividend Rate, $ 0.48
Annual Dividend Yield 1.23%
Most Recent Dividend 0.120 on 02/28/23
Next Ex-Dividends Date 02/28/23
Dividend Payable Date 03/15/23
Dividend Payout Ratio 15.58%
Most Recent Split 1-4 on 12/05/16

COWN Ratios

Ratio
Price/Earnings ttm 15.47
Price/Earnings forward 9.77
Price/Earnings to Growth N/A
Return-on-Equity % 7.07%
Return-on-Assets % 0.99%
Profit Margin % 4.97%
Debt/Equity 1.41
Price/Sales 0.71
Price/Cash Flow 9.27
Price/Book 0.89
Book Value/Share 0.00
Interest Coverage 0.00

COWN Dividends

Date Value
02/28/23 $0.1200
11/30/22 $0.1200
08/31/22 $0.1200
05/31/22 $0.1200
02/28/22 $0.1200
11/30/21 $0.1000
08/31/21 $0.1000
05/28/21 $0.1000
02/26/21 $0.0800
11/30/20 $0.0800
08/31/20 $0.0400
05/29/20 $0.0400
02/28/20 $0.0400
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar